APO Research
Talk to an analyst

APO RESEARCH · REPORT

Percutaneous Transluminal Angioplasty Instrument

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Percutaneous Transluminal Angioplasty Instrument Market Outlook and Growth Opportunities 2026

8 January 2026204 pages

Choose your research edition.

Industry ResearchPercutaneous Transluminal Angioplasty Instrument Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Percutaneous Transluminal Angioplasty Instrument Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Percutaneous Transluminal Angioplasty Instrument Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Percutaneous Transluminal Angioplasty Instrument Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Percutaneous Transluminal Angioplasty Instrument Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Percutaneous Transluminal Angioplasty Instrument market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Percutaneous Transluminal Angioplasty Instrument is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Percutaneous Transluminal Angioplasty Instrument is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Percutaneous Transluminal Angioplasty Instrument is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Percutaneous Transluminal Angioplasty Instrument market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Percutaneous Transluminal Angioplasty Instrument market include Abbott, Boston Scientific, Medtronic, Terumo Medical, Lepu Medical, MicroPort, Biosensors, B.Braun and Atrium Medical, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Percutaneous Transluminal Angioplasty Instrument market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Percutaneous Transluminal Angioplasty Instrument and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Percutaneous Transluminal Angioplasty Instrument revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Percutaneous Transluminal Angioplasty Instrument market.

Percutaneous Transluminal Angioplasty Instrument Segment by Company

Abbott

Boston Scientific

Medtronic

Terumo Medical

Lepu Medical

MicroPort

Biosensors

B.Braun

Atrium Medical

Biotronik

Asahi Intecc

Cardinal

Integer

Cook Medical

TE Connectivity

Merit

SP Medical

Percutaneous Transluminal Angioplasty Instrument Segment by Type

Introducer

Angiographic Catheter

Balloon Catheter

Guide Wire

Stent

Others

Percutaneous Transluminal Angioplasty Instrument Segment by Application

Below 40 Years Old

40 ~ 60 Years Old

Above 60 Years Old

Percutaneous Transluminal Angioplasty Instrument Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Percutaneous Transluminal Angioplasty Instrument status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Percutaneous Transluminal Angioplasty Instrument key companies, revenue, market share, and recent developments.

3. To split the Percutaneous Transluminal Angioplasty Instrument breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Percutaneous Transluminal Angioplasty Instrument market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Percutaneous Transluminal Angioplasty Instrument significant trends, drivers, influence factors in global and regions.

6. To analyze Percutaneous Transluminal Angioplasty Instrument competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Percutaneous Transluminal Angioplasty Instrument market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Percutaneous Transluminal Angioplasty Instrument and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Percutaneous Transluminal Angioplasty Instrument.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Percutaneous Transluminal Angioplasty Instrument industry.

Chapter 3: Detailed analysis of Percutaneous Transluminal Angioplasty Instrument company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Percutaneous Transluminal Angioplasty Instrument in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Percutaneous Transluminal Angioplasty Instrument in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Percutaneous Transluminal Angioplasty Instrument Industry Trends Table 2. Percutaneous Transluminal Angioplasty Instrument Industry Drivers Table 3. Percutaneous Transluminal Angioplasty Instrument Industry Opportunities and Challenges Table 4. Percutaneous Transluminal Angioplasty Instrument Industry Restraints Table 5. Global Percutaneous Transluminal Angioplasty Instrument Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Percutaneous Transluminal Angioplasty Instrument Revenue Share by Company (2021-2026) Table 7. Global Percutaneous Transluminal Angioplasty Instrument Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Percutaneous Transluminal Angioplasty Instrument Key Company Manufacturing Base & Headquarters Table 9. Global Percutaneous Transluminal Angioplasty Instrument Company, Product Type & Application Table 10. Global Percutaneous Transluminal Angioplasty Instrument Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Percutaneous Transluminal Angioplasty Instrument by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Introducer Table 15. Significant Companies of Angiographic Catheter Table 16. Significant Companies of Balloon Catheter Table 17. Significant Companies of Guide Wire Table 18. Significant Companies of Stent Table 19. Significant Companies of Others Table 20. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type (2021-2026) Table 24. Global Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Below 40 Years Old Table 26. Significant Companies of 40 ~ 60 Years Old Table 27. Significant Companies of Above 60 Years Old Table 28. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application (2021-2026) Table 32. Global Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application (2027-2032) Table 33. Global Percutaneous Transluminal Angioplasty Instrument Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Region (2021-2026) Table 36. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Region (2027-2032) Table 38. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Percutaneous Transluminal Angioplasty Instrument Sales Value Market Share by Country (2021-2026) Table 41. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Percutaneous Transluminal Angioplasty Instrument Sales Value Market Share by Country (2027-2032) Table 43. Abbott Company Information Table 44. Abbott Business Overview Table 45. Abbott Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Abbott Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 47. Abbott Recent Development Table 48. Boston Scientific Company Information Table 49. Boston Scientific Business Overview Table 50. Boston Scientific Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Boston Scientific Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 52. Boston Scientific Recent Development Table 53. Medtronic Company Information Table 54. Medtronic Business Overview Table 55. Medtronic Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Medtronic Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 57. Medtronic Recent Development Table 58. Terumo Medical Company Information Table 59. Terumo Medical Business Overview Table 60. Terumo Medical Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Terumo Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 62. Terumo Medical Recent Development Table 63. Lepu Medical Company Information Table 64. Lepu Medical Business Overview Table 65. Lepu Medical Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Lepu Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 67. Lepu Medical Recent Development Table 68. MicroPort Company Information Table 69. MicroPort Business Overview Table 70. MicroPort Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. MicroPort Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 72. MicroPort Recent Development Table 73. Biosensors Company Information Table 74. Biosensors Business Overview Table 75. Biosensors Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Biosensors Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 77. Biosensors Recent Development Table 78. B.Braun Company Information Table 79. B.Braun Business Overview Table 80. B.Braun Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. B.Braun Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 82. B.Braun Recent Development Table 83. Atrium Medical Company Information Table 84. Atrium Medical Business Overview Table 85. Atrium Medical Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Atrium Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 87. Atrium Medical Recent Development Table 88. Biotronik Company Information Table 89. Biotronik Business Overview Table 90. Biotronik Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Biotronik Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 92. Biotronik Recent Development Table 93. Asahi Intecc Company Information Table 94. Asahi Intecc Business Overview Table 95. Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 97. Asahi Intecc Recent Development Table 98. Cardinal Company Information Table 99. Cardinal Business Overview Table 100. Cardinal Percutaneous Transluminal Angioplasty Instrument Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Cardinal Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 102. Cardinal Recent Development Table 103. Integer Company Information Table 104. Integer Business Overview Table 105. Integer Percutaneous Transluminal Angioplasty Instrument Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Integer Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 107. Integer Recent Development Table 108. Cook Medical Company Information Table 109. Cook Medical Business Overview Table 110. Cook Medical Percutaneous Transluminal Angioplasty Instrument Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Cook Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 112. Cook Medical Recent Development Table 113. TE Connectivity Company Information Table 114. TE Connectivity Business Overview Table 115. TE Connectivity Percutaneous Transluminal Angioplasty Instrument Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. TE Connectivity Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 117. TE Connectivity Recent Development Table 118. Merit Company Information Table 119. Merit Business Overview Table 120. Merit Percutaneous Transluminal Angioplasty Instrument Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Merit Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 122. Merit Recent Development Table 123. SP Medical Company Information Table 124. SP Medical Business Overview Table 125. SP Medical Percutaneous Transluminal Angioplasty Instrument Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. SP Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 127. SP Medical Recent Development Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Percutaneous Transluminal Angioplasty Instrument Product Image Figure 2. Global Percutaneous Transluminal Angioplasty Instrument Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 4. Global Percutaneous Transluminal Angioplasty Instrument Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Introducer Image Figure 8. Angiographic Catheter Image Figure 9. Balloon Catheter Image Figure 10. Guide Wire Image Figure 11. Stent Image Figure 12. Others Image Figure 13. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Percutaneous Transluminal Angioplasty Instrument Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type (2021-2032) Figure 16. Below 40 Years Old Image Figure 17. 40 ~ 60 Years Old Image Figure 18. Above 60 Years Old Image Figure 19. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Percutaneous Transluminal Angioplasty Instrument Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application (2021-2032) Figure 22. Global Percutaneous Transluminal Angioplasty Instrument Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Percutaneous Transluminal Angioplasty Instrument Sales Value (2021-2032) & (US$ Million) Figure 25. North America Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Percutaneous Transluminal Angioplasty Instrument Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Percutaneous Transluminal Angioplasty Instrument Sales Value (2021-2032) & (US$ Million) Figure 31. South America Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Introducer
  • Angiographic Catheter
  • Balloon Catheter
  • Guide Wire
  • Stent
  • Others
Applications
  • Below 40 Years Old
  • 40 ~ 60 Years Old
  • Above 60 Years Old
Companies covered
  • Abbott
  • Boston Scientific
  • Medtronic
  • Terumo Medical
  • Lepu Medical
  • MicroPort
  • Biosensors
  • B.Braun
  • Atrium Medical
  • Biotronik
  • Asahi Intecc
  • Cardinal
  • Integer
  • Cook Medical
  • TE Connectivity
  • Merit
  • SP Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Percutaneous Transluminal Angioplasty Instrument Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Percutaneous Transluminal Angioplasty Instrument Market Dynamics
  1. 2.1 Percutaneous Transluminal Angioplasty Instrument Industry Trends
  2. 2.2 Percutaneous Transluminal Angioplasty Instrument Industry Drivers
  3. 2.3 Percutaneous Transluminal Angioplasty Instrument Industry Opportunities and Challenges
  4. 2.4 Percutaneous Transluminal Angioplasty Instrument Industry Restraints
3 Percutaneous Transluminal Angioplasty Instrument Market by Company
  1. 3.1 Global Percutaneous Transluminal Angioplasty Instrument Company Revenue Ranking in 2025
  2. 3.2 Global Percutaneous Transluminal Angioplasty Instrument Revenue by Company (2021-2026)
  3. 3.3 Global Percutaneous Transluminal Angioplasty Instrument Company Ranking (2024-2026)
  4. 3.4 Global Percutaneous Transluminal Angioplasty Instrument Company Manufacturing Base and Headquarters
  5. 3.5 Global Percutaneous Transluminal Angioplasty Instrument Company Product Type and Application
  6. 3.6 Global Percutaneous Transluminal Angioplasty Instrument Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Percutaneous Transluminal Angioplasty Instrument Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Percutaneous Transluminal Angioplasty Instrument Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Percutaneous Transluminal Angioplasty Instrument Market by Type
  1. 4.1 Percutaneous Transluminal Angioplasty Instrument Type Introduction
  2. 4.1.1 Introducer
  3. 4.1.2 Angiographic Catheter
  4. 4.1.3 Balloon Catheter
  5. 4.1.4 Guide Wire
  6. 4.1.5 Stent
  7. 4.1.6 Others
  8. 4.2 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Type
  9. 4.2.1 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (2021-2032)
  11. 4.2.3 Global Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type (2021-2032)
5 Percutaneous Transluminal Angioplasty Instrument Market by Application
  1. 5.1 Percutaneous Transluminal Angioplasty Instrument Application Introduction
  2. 5.1.1 Below 40 Years Old
  3. 5.1.2 40 ~ 60 Years Old
  4. 5.1.3 Above 60 Years Old
  5. 5.2 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Application
  6. 5.2.1 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Application (2021-2032)
  8. 5.2.3 Global Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application (2021-2032)
6 Percutaneous Transluminal Angioplasty Instrument Regional Value Analysis
  1. 6.1 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Region (2021-2032)
  3. 6.2.1 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Region: 2021-2026
  4. 6.2.2 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Percutaneous Transluminal Angioplasty Instrument Sales Value (2021-2032)
  7. 6.3.2 North America Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Percutaneous Transluminal Angioplasty Instrument Sales Value (2021-2032)
  10. 6.4.2 Europe Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Percutaneous Transluminal Angioplasty Instrument Sales Value (2021-2032)
  16. 6.6.2 South America Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Country, 2025 VS 2032
7 Percutaneous Transluminal Angioplasty Instrument Country-level Value Analysis
  1. 7.1 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Country (2021-2032)
  3. 7.2.1 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Country (2021-2026)
  4. 7.2.2 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Percutaneous Transluminal Angioplasty Instrument Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Boston Scientific
  8. 8.2.1 Boston Scientific Company Information
  9. 8.2.2 Boston Scientific Business Overview
  10. 8.2.3 Boston Scientific Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boston Scientific Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  12. 8.2.5 Boston Scientific Recent Developments
  13. 8.3 Medtronic
  14. 8.3.1 Medtronic Company Information
  15. 8.3.2 Medtronic Business Overview
  16. 8.3.3 Medtronic Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Medtronic Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  18. 8.3.5 Medtronic Recent Developments
  19. 8.4 Terumo Medical
  20. 8.4.1 Terumo Medical Company Information
  21. 8.4.2 Terumo Medical Business Overview
  22. 8.4.3 Terumo Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Terumo Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  24. 8.4.5 Terumo Medical Recent Developments
  25. 8.5 Lepu Medical
  26. 8.5.1 Lepu Medical Company Information
  27. 8.5.2 Lepu Medical Business Overview
  28. 8.5.3 Lepu Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lepu Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  30. 8.5.5 Lepu Medical Recent Developments
  31. 8.6 MicroPort
  32. 8.6.1 MicroPort Company Information
  33. 8.6.2 MicroPort Business Overview
  34. 8.6.3 MicroPort Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  35. 8.6.4 MicroPort Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  36. 8.6.5 MicroPort Recent Developments
  37. 8.7 Biosensors
  38. 8.7.1 Biosensors Company Information
  39. 8.7.2 Biosensors Business Overview
  40. 8.7.3 Biosensors Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Biosensors Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  42. 8.7.5 Biosensors Recent Developments
  43. 8.8 B.Braun
  44. 8.8.1 B.Braun Company Information
  45. 8.8.2 B.Braun Business Overview
  46. 8.8.3 B.Braun Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  47. 8.8.4 B.Braun Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  48. 8.8.5 B.Braun Recent Developments
  49. 8.9 Atrium Medical
  50. 8.9.1 Atrium Medical Company Information
  51. 8.9.2 Atrium Medical Business Overview
  52. 8.9.3 Atrium Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Atrium Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  54. 8.9.5 Atrium Medical Recent Developments
  55. 8.10 Biotronik
  56. 8.10.1 Biotronik Company Information
  57. 8.10.2 Biotronik Business Overview
  58. 8.10.3 Biotronik Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Biotronik Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  60. 8.10.5 Biotronik Recent Developments
  61. 8.11 Asahi Intecc
  62. 8.11.1 Asahi Intecc Company Information
  63. 8.11.2 Asahi Intecc Business Overview
  64. 8.11.3 Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  66. 8.11.5 Asahi Intecc Recent Developments
  67. 8.12 Cardinal
  68. 8.12.1 Cardinal Company Information
  69. 8.12.2 Cardinal Business Overview
  70. 8.12.3 Cardinal Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Cardinal Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  72. 8.12.5 Cardinal Recent Developments
  73. 8.13 Integer
  74. 8.13.1 Integer Company Information
  75. 8.13.2 Integer Business Overview
  76. 8.13.3 Integer Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Integer Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  78. 8.13.5 Integer Recent Developments
  79. 8.14 Cook Medical
  80. 8.14.1 Cook Medical Company Information
  81. 8.14.2 Cook Medical Business Overview
  82. 8.14.3 Cook Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cook Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  84. 8.14.5 Cook Medical Recent Developments
  85. 8.15 TE Connectivity
  86. 8.15.1 TE Connectivity Company Information
  87. 8.15.2 TE Connectivity Business Overview
  88. 8.15.3 TE Connectivity Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  89. 8.15.4 TE Connectivity Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  90. 8.15.5 TE Connectivity Recent Developments
  91. 8.16 Merit
  92. 8.16.1 Merit Company Information
  93. 8.16.2 Merit Business Overview
  94. 8.16.3 Merit Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Merit Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  96. 8.16.5 Merit Recent Developments
  97. 8.17 SP Medical
  98. 8.17.1 SP Medical Company Information
  99. 8.17.2 SP Medical Business Overview
  100. 8.17.3 SP Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  101. 8.17.4 SP Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  102. 8.17.5 SP Medical Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst